Prosidion Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A PK-PD Study of PSN821 in Type 2 Diabetes Patients (T2DM) (NCT01386099) | Prosidion Ltd. | 2011-05-01 |
Track Prosidion Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.